Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Phase II Clinical Study of Proton Therapy for Recurrent Nasopharyngeal Carcinoma

NCT07412314 is registered in ClinicalTrials.gov with Guangzhou Concord Cancer Center as lead sponsor.

NCT NCT07412314
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07412314 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Phase II Clinical Study of Proton Therapy for Recurrent Nasopharyngeal Carcinoma
Lead sponsor
Guangzhou Concord Cancer Center
Phase
Not applicable
Overall status
Recruiting
Start date
March 10, 2025
Completion date
March 10, 2028
Enrollment
52 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent nasopharyngeal carcinoma